Infection prevention in practice · 2026
Risk and prognosis of infection and colonisation by carbapenemase-producing Citrobacter freundii in the North Denmark Region during 2012-2023: a matched case-control and cohort study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Saarup Lukas Holm, Andersen Kasper Vium, Søgaard Kirstine Kobberøe, Skals Regitze Gyldenholm, Koch Kristoffer, Ank Nina, Azuz Samuel, Jensen Paw, Stender Mogens Tornby, Hammerum Anette M, Hasman Henrik, Nielsen Hans Linde
Аннотация
BACKGROUND: Since October 2012, New Delhi metallo-beta-lactamase (NDM)-1-producing Citrobacter freundii has caused a prolonged outbreak at Aalborg University Hospital, Denmark. Despite infection control efforts, transmission persisted in haematology and abdominal surgery wards. This study aimed to identify risk factors for infection or colonisation with ST18 NDM-1-producing C. freundii and to assess all-cause mortality.
METHODS: We conducted a matched case-control and cohort study (2012-2023). Cases were patients with ST18 NDM-1-producing C. freundii detected in clinical or screening specimens. For each case, eight controls without C. freundii were selected from the same ward using risk-set sampling and matched on specimen date. Conditional logistic regression was used to identify risk factors, and Cox regression was used to estimate hazard ratios (HRs) for all-cause mortality.
RESULTS: Sixty-nine cases and 552 controls were included. The strongest risk factors were prolonged hospital stay (>14 vs ≤7 days; odds ratio [OR]=6.4, 95% confidence interval [CI]= 3.6-11.3), peritoneal disease (OR=4.4, 95% CI= 1.5-13.3), pancreatobiliary disorders (OR=5.5, 95% CI= 3.0-10.3), biliary tract surgery (OR=4.6, 95% CI= 2.7-7.8), pancreatic surgery (OR=4.4, 95% CI= 2.2-8.6), and in-hospital exposure to vancomycin (OR=13.9, 95% CI= 6.8-28.4), beta-lactam/beta-lactamase inhibitors (OR=8.8, 95% CI= 4.2-18.2), fluoroquinolones (OR=8.2, 95% CI= 4.6-14.9), or systemic antifungals (OR=8.6, 95% CI= 4.7-15.6). Thirty-day mortality was higher among cases (adjusted HR=2.2, 95% CI= 1.1-4.3), while 90- and 365-day mortality did not differ.
CONCLUSION: Infection or colonisation with ST18 NDM-1-producing C. freundii was associated with prolonged hospitalisation, abdominal infections, invasive surgical procedures, broad-spectrum antimicrobial exposure, and higher short-term mortality, likely reflecting underlying disease severity.
METHODS: We conducted a matched case-control and cohort study (2012-2023). Cases were patients with ST18 NDM-1-producing C. freundii detected in clinical or screening specimens. For each case, eight controls without C. freundii were selected from the same ward using risk-set sampling and matched on specimen date. Conditional logistic regression was used to identify risk factors, and Cox regression was used to estimate hazard ratios (HRs) for all-cause mortality.
RESULTS: Sixty-nine cases and 552 controls were included. The strongest risk factors were prolonged hospital stay (>14 vs ≤7 days; odds ratio [OR]=6.4, 95% confidence interval [CI]= 3.6-11.3), peritoneal disease (OR=4.4, 95% CI= 1.5-13.3), pancreatobiliary disorders (OR=5.5, 95% CI= 3.0-10.3), biliary tract surgery (OR=4.6, 95% CI= 2.7-7.8), pancreatic surgery (OR=4.4, 95% CI= 2.2-8.6), and in-hospital exposure to vancomycin (OR=13.9, 95% CI= 6.8-28.4), beta-lactam/beta-lactamase inhibitors (OR=8.8, 95% CI= 4.2-18.2), fluoroquinolones (OR=8.2, 95% CI= 4.6-14.9), or systemic antifungals (OR=8.6, 95% CI= 4.7-15.6). Thirty-day mortality was higher among cases (adjusted HR=2.2, 95% CI= 1.1-4.3), while 90- and 365-day mortality did not differ.
CONCLUSION: Infection or colonisation with ST18 NDM-1-producing C. freundii was associated with prolonged hospitalisation, abdominal infections, invasive surgical procedures, broad-spectrum antimicrobial exposure, and higher short-term mortality, likely reflecting underlying disease severity.